Advisor Group Holdings, Inc. Adaptive Biotechnologies Corp Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 57,453 shares of ADPT stock, worth $329,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,453

Previous 57,003 0.79%

Holding current value

$329,205

Previous $206,000 42.72%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.37 - $5.12 $1,516 - $2,304	450 Added 0.79%	57,453 $294,000
Q2 2024 Aug 13, 2024	BUY	$2.34 - $3.96 $5,878 - $9,947	2,512 Added 4.61%	57,003 $206,000
Q1 2024 May 10, 2024	SELL	$2.88 - $4.8 $3,784 - $6,307	-1,314 Reduced 2.35%	54,491 $174,000
Q4 2023 Feb 12, 2024	SELL	$3.46 - $5.33 $195,981 - $301,901	-56,642 Reduced 50.37%	55,805 $273,000
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $477,112 - $794,246	94,105 Added 513.06%	112,447 $612,000
Q2 2023 Aug 10, 2023	SELL	$6.19 - $8.78 $206,820 - $293,357	-33,412 Reduced 64.56%	18,342 $123,000
Q1 2023 May 12, 2023	BUY	$7.8 - $10.11 $23,212 - $30,087	2,976 Added 6.1%	51,754 $456,000
Q4 2022 Feb 10, 2023	SELL	$6.26 - $9.34 $15,324 - $22,864	-2,448 Reduced 4.78%	48,778 $372,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $25,428 - $49,565	-3,912 Reduced 7.09%	51,226 $365,000
Q2 2022 Aug 10, 2022	BUY	$6.4 - $14.73 $29,894 - $68,803	4,671 Added 9.26%	55,138 $446,000
Q1 2022 May 04, 2022	SELL	$10.12 - $28.9 $18,560 - $53,002	-1,834 Reduced 3.51%	50,467 $699,000
Q3 2021 Nov 05, 2021	SELL	$30.02 - $39.87 $1,080 - $1,435	-36 Reduced 0.07%	52,301 $1.78 Million
Q2 2021 Aug 02, 2021	BUY	$32.22 - $44.59 $225,636 - $312,263	7,003 Added 15.45%	52,337 $2.14 Million
Q1 2021 May 13, 2021	BUY	$37.26 - $67.74 $101,570 - $184,659	2,726 Added 6.4%	45,334 $1.83 Million
Q4 2020 Feb 10, 2021	SELL	$45.01 - $65.47 $382,900 - $556,953	-8,507 Reduced 16.64%	42,608 $2.52 Million
Q3 2020 Nov 12, 2020	BUY	$35.79 - $48.81 $87,506 - $119,340	2,445 Added 5.02%	51,115 $2.48 Million
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $3.37 Million - $6.54 Million	-135,110 Reduced 73.52%	48,670 $2.35 Million
Q1 2020 May 18, 2020	BUY	$16.96 - $34.16 $3.12 Million - $6.28 Million	183,780 New	183,780 $5.11 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $819M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Adaptive Biotechnologies Corp Transaction History